Literature DB >> 11605773

Reversible left ventricular systolic dysfunction--reversibility of coronary microvascular abnormality.

J Ako1, K Takenaka, K Uno, F Nakamura, T Shoji, K Iijima, Y Ohike, S Kim, T Watanabe, M Yoshizumi, Y Ouchi.   

Abstract

Reversible left ventricular wall motion abnormalities mimicking myocardial infarction have been reported in patients with a noncardiac illness. Their coronary angiograms do not demonstrate organic stenosis or epicardial coronary vasospasm. In this article, two cases of reversible left ventricular contraction abnormality are presented. Electrocardiography showed deep inverted T waves in precordial leads, and the echocardiography revealed diffuse akinesis of the apical region in the acute phase. Coronary angiography showed no significant stenosis or occlusion in either patient. Thallium scintigraphy showed no defect, while the metaiodobenzylguanidine scintigraphy demonstrated significant defects in the apex. The relative coronary flow reserve ratio, measured with an intracoronary Doppler flow wire, was significantly reduced in both patients. Myocardial contrast echocardiography revealed a reversible perfusion defect in the apex in the acute phase in case 2. Transiently impaired coronary microcirculation was thought to be involved in the pathogenesis of the reversible left ventricular dysfunction observed in these patients.

Entities:  

Mesh:

Year:  2001        PMID: 11605773     DOI: 10.1536/jhj.42.355

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  13 in total

Review 1.  Tako-tsubo cardiomyopathy (apical ballooning).

Authors:  Holger M Nef; Helge Möllmann; Albrecht Elsässer
Journal:  Heart       Date:  2007-10       Impact factor: 5.994

2.  [Cardiac magnetic resonance tomography in the diagnostics of restrictive and unclassified cardiopathies].

Authors:  U Kramer; A E May; S Mangold; P Krumm; C D Claussen
Journal:  Radiologe       Date:  2013-01       Impact factor: 0.635

Review 3.  Mechanisms of stress (Takotsubo) cardiomyopathy.

Authors:  Holger M Nef; Helge Möllmann; Yoshihiro J Akashi; Christian W Hamm
Journal:  Nat Rev Cardiol       Date:  2010-03-02       Impact factor: 32.419

4.  Takotsubo cardiomyopathy: FDG myocardial uptake pattern in fasting patients. Comparison of PET/CT, SPECT, and ECHO results.

Authors:  Malgorzata Kobylecka; Monika Budnik; Janusz Kochanowski; Radoslaw Piatkowski; Marek Chojnowski; Katarzyna Fronczewska-Wieniawska; Tomasz Mazurek; Joanna Maczewska; Michał Peller; Grzegorz Opolski; Leszek Krolicki
Journal:  J Nucl Cardiol       Date:  2017-01-04       Impact factor: 5.952

5.  Reversible impairment of coronary flow reserve in takotsubo cardiomyopathy: a myocardial PET study.

Authors:  Mauro Feola; Stephane Chauvie; Gian Luca Rosso; Alberto Biggi; Flavio Ribichini; Marco Bobbio
Journal:  J Nucl Cardiol       Date:  2008-07-31       Impact factor: 5.952

6.  Angiographic long-term follow-up of primary apical ballooning of the left ventricle.

Authors:  Massimo Giordan; Gianluca Rigatelli; Paolo Cardaioli; Francesca Di Marco
Journal:  Int J Cardiovasc Imaging       Date:  2006-03-15       Impact factor: 2.357

7.  Stress cardiomyopathy (takotsubo cardiomyopathy).

Authors:  Samer Khouri; Naser Imran
Journal:  Clin Med Cardiol       Date:  2009-09-17

Review 8.  Unique morphological variations of transient midventricular syndrome: a case series-review.

Authors:  Dilbahar S Mohar; Jin Kyung Kim; Pranav M Patel
Journal:  Echocardiography       Date:  2012-07-02       Impact factor: 1.724

9.  Stunned myocardium in transient left ventricular apical ballooning: a serial study of dual I-123 BMIPP and Tl-201 SPECT.

Authors:  Akira Sato; Kazutaka Aonuma; Toshihiro Nozato; Yukio Sekiguchi; Osamu Okazaki; Kazuo Kubota; Michiaki Hiroe
Journal:  J Nucl Cardiol       Date:  2008-06-12       Impact factor: 5.952

10.  Takotsubo cardiomyopathy, or broken-heart syndrome.

Authors:  Salim S Virani; A Nasser Khan; Cesar E Mendoza; Alexandre C Ferreira; Eduardo de Marchena
Journal:  Tex Heart Inst J       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.